Impact of adherence to disease-modifying therapies on employment among veterans with multiple sclerosis

References

• Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517.
   PubMed Web of Science ®Google Scholar
• Aronson JK. Compliance, concordance, adherence. Br J Clin Pharmacol. 2007;63(4):383–384.
   PubMed Web of Science ®Google Scholar
• Treadaway K, Cutter G, Salter A, et al. Factors that influence adherence with disease-modifying therapy in MS. J Neurol. 2009;256(4):568–576.
   PubMed Web of Science ®Google Scholar
• Devonshire V, Lapierre Y, Macdonell R, for the GAP Study Group, et al. u. a. The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 2011;18(1):69–77.
   PubMed Web of Science ®Google Scholar
• Menzin J, Caon C, Nichols C, et al. Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis. J Manag Care Pharm. 2013;19(1 Suppl A):S24–S40.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Ehlken B, Limmroth V, C.A.R.E. Study Group, et al. Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program. BMC Neurol. 2015;15:170.
   PubMed Web of Science ®Google Scholar
• Zhang T, Kingwell E, Zhu F, et al. Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study. BMJ Open. 2017;7(9):e018612.
   PubMed Web of Science ®Google Scholar
• Busche KD, Fisk JD, Murray TJ, et al. Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci. 2003;30(2):137–142.
   PubMed Web of Science ®Google Scholar
• Honan CA, Brown RF, Hine DW, et al. The multiple sclerosis work difficulties questionnaire. Mult Scler. 2012;18(6):871–880.
   PubMed Web of Science ®Google Scholar
• Honarmand K, Akbar N, Kou N, et al. Predicting employment status in multiple sclerosis patients: The utility of the MS functional composite. J Neurol. 2011;258(2):244–249.
   PubMed Web of Science ®Google Scholar
• Julian LJ, Vella L, Vollmer T, et al. Employment in multiple sclerosis. J Neurol. 2008;255(9):1354–1360.
   PubMed Web of Science ®Google Scholar
• Coyne KS, Boscoe AN, Currie BM, et al. Understanding Drivers of Employment Changes in a Multiple Sclerosis Population. Int J MS Care. 2015;17(5):245–252.
   PubMedGoogle Scholar
• Johnson KL, Amtmann D, Yorkston KM, et al. Medical, psychological, social, and programmatic barriers to employment for people with multiple sclerosis. J Rehabil. 2004;70:38–50.
   Web of Science ®Google Scholar
• Pfleger CC, Flachs EM, Koch-Henriksen N. Social consequences of multiple sclerosis (1): Early pension and temporary unemployment-a historical prospective cohort study. Mult Scler. 2010;16(1):121–126.
   PubMedGoogle Scholar
• Flensner G, Landtblom AM, Soderhamn O, et al. Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study. BMC Public Health. 2013;13(1):224.
   PubMedGoogle Scholar
• Miller A, Dishon S. Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Qual Life Res. 2006;15(2):259–271.
   PubMed Web of Science ®Google Scholar
• National Multiple Sclerosis Society. Comprehensive care. [cited 2020 Jan 27]. Available from: https://www.nationalmssociety.org/Living-Well-With-MS/Work-and-Home/Employment. Thus, employment can be regarded as a marker of overall functioning of the individual patient and have also important impact on quality of life (QoL).
   Google Scholar
• Rudge P. Are clinical trials of therapeutic agents for MS long enough? Lancet. 1999;353(9158):1033–1034.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–127.
   PubMed Web of Science ®Google Scholar
• Scheinthal SM, Steer RA, Giffin L, et al. Depression Inventory-Fast screen for medical patients. Aging Ment Health. 2001;5(2):143–148.
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Kümpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. 2002;8(6):523–526.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology. 1996;46(4):907–911.
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Joyce C, Holt EW, et al. Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension. Pharmacotherapy. 2013;33(8):798–811.
   PubMed Web of Science ®Google Scholar
• Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11(7):449–457.
   PubMed Web of Science ®Google Scholar
• Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–887.
   PubMed Web of Science ®Google Scholar
• Briesacher BA, Andrade SE, Fouayzi H, et al. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–443.
   PubMed Web of Science ®Google Scholar
• Rumrill PD, Roessler RT, Li J, et al. The employment concerns of Americans with multiple sclerosis: perspectives from a national sample. Work. 2015;52(4):735–748.
   PubMedGoogle Scholar
• Bøe Lunde HM, Telstad W, Grytten N, et al. Employment among patients with multiple sclerosis-a population study. PLOS One. 2014;9(7):e103317.
   PubMed Web of Science ®Google Scholar
• Roessler R, Rumrill P, Fitzgerald S. Predictors of employment status for persons with multiple sclerosis. Rehab Counsel Bull. 2004;47(2):96–103.
   Web of Science ®Google Scholar
• Kobelt G, Langdon D, Jönsson L. The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: the case of multiple sclerosis. Mult Scler. 2019;25(5):740–749.
   PubMed Web of Science ®Google Scholar
• Forslin M, Fink K, Hammar U, et al. Predictors for employment status in people with multiple sclerosis: a 10-year longitudinal observational study. Arch Phys Med Rehabil. 2018;99(8):1483–1490.
   PubMed Web of Science ®Google Scholar
• Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000;343(13):938–952.
   PubMed Web of Science ®Google Scholar
• Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. 2008;71(2):129–135.
   PubMed Web of Science ®Google Scholar
• Bruce JM, Hancock LM, Lynch SG. Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report. Mult Scler. 2010;16(1):112–120.
   PubMed Web of Science ®Google Scholar